Profile data is unavailable for this security.
About the company
SNDL Inc. is a Canada-based private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, Spiritleaf, Superette and Firesale. The Company is specializing in low-cost biomass sourcing, indoor cultivation, product innovation, low-cost manufacturing facilities, and a cannabis brand portfolio that includes Top Leaf, Contraband, Citizen Stash, Sundial Cannabis, Palmetto, Spiritleaf Selects Bon Jak, Versus, Value Buds, Namaste, Re-up, Grasslands and Vacay. Its segments include Liquor Retail, Cannabis Retail, Cannabis Operations and Investments. Its Liquor retail segment includes the sale of wines, beers and spirits through owned liquor stores. Cannabis retail segment includes the private sale of adult-use cannabis through owned and franchised retail cannabis stores. Its Cannabis operations include the cultivation, distribution and sale of cannabis for the adult-use and medical markets domestically and for export.
- Revenue in USD (TTM)669.74m
- Net income in USD-82.92m
- Incorporated2006
- Employees2.52k
- LocationSNDL Inc919 11 AVENUE SW, SUITE 300Calgary T2R1P3CanadaCAN
- Phone+1 (403) 948-5227
- Fax+1 (403) 948-5227
- Websitehttps://www.sndl.com/
Mergers & acquisitions
Acquired company | SNDL:NAQ since announced | Transaction value |
---|---|---|
Nova Cannabis Inc | -3.48% | 27.48m |
Indiva Ltd | -5.37% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Theravance Biopharma Inc | 62.02m | -45.65m | 393.82m | 99.00 | -- | 2.03 | -- | 6.35 | -0.924 | -0.924 | 1.25 | 3.96 | 0.1534 | -- | 4.12 | 626,434.30 | -11.29 | -40.51 | -12.00 | -48.50 | -- | -- | -73.61 | -305.27 | -- | -- | 0.1305 | -- | 11.84 | -0.9956 | 40.54 | -- | -19.24 | -- |
Esperion Therapeutics Inc | 277.79m | -98.50m | 400.30m | 240.00 | -- | -- | -- | 1.44 | -0.8758 | -0.8758 | 1.84 | -1.77 | 0.9466 | 0.7763 | 5.49 | 1,157,450.00 | -33.56 | -69.45 | -64.71 | -101.81 | 81.82 | -- | -35.46 | -147.44 | 1.49 | 0.0972 | -- | -- | 54.14 | -- | 10.45 | -- | -- | -- |
Zevra Therapeutics Inc | 23.99m | -65.75m | 409.89m | 65.00 | -- | 10.07 | -- | 17.09 | -1.67 | -1.67 | 0.6106 | 0.7734 | 0.1919 | -- | 2.09 | 369,015.40 | -52.61 | -32.11 | -65.34 | -39.89 | 71.78 | -- | -274.10 | -128.42 | -- | -112.94 | 0.6423 | -- | 170.26 | -- | -72.00 | -- | 69.75 | -- |
Elite Pharmaceuticals Inc | 66.45m | 19.58m | 425.71m | 64.00 | 20.83 | 7.31 | 20.21 | 6.41 | 0.0191 | 0.0191 | 0.064 | 0.0545 | 0.9892 | 2.91 | 4.98 | 1,038,252.00 | 29.15 | 19.07 | 36.18 | 24.29 | 45.27 | 46.63 | 29.47 | 20.77 | 2.09 | 1.44 | 0.1389 | 0.00 | 65.79 | 49.55 | 464.56 | -- | 111.50 | -- |
Xeris Biopharma Holdings Inc | 181.41m | -59.56m | 436.57m | 377.00 | -- | -- | -- | 2.41 | -0.4215 | -0.4215 | 1.28 | -0.1295 | 0.5493 | 0.7428 | 4.99 | 481,201.60 | -18.04 | -43.60 | -23.57 | -56.57 | 83.72 | 78.23 | -32.83 | -143.08 | 1.69 | -1.59 | 1.09 | -- | 48.68 | 131.50 | 34.23 | -- | 8.43 | -- |
Aquestive Therapeutics Inc | 58.36m | -25.72m | 441.64m | 135.00 | -- | -- | -- | 7.57 | -0.3565 | -0.3565 | 0.7874 | -0.3896 | 0.6685 | 2.85 | 7.25 | 432,296.30 | -29.46 | -76.63 | -42.14 | -123.85 | 68.49 | 64.24 | -44.07 | -102.95 | 6.98 | -2.67 | -- | -- | 6.09 | -5.59 | 85.54 | -- | -11.42 | -- |
Eyepoint Pharmaceuticals Inc | 50.39m | -86.82m | 466.14m | 121.00 | -- | 1.99 | -- | 9.25 | -1.80 | -1.80 | 1.08 | 4.38 | 0.2016 | 1.10 | 8.18 | 416,454.50 | -34.74 | -40.44 | -47.07 | -47.79 | 91.35 | 83.45 | -172.29 | -186.23 | 4.69 | -- | 0.00 | -- | 11.14 | -- | 30.77 | -- | -- | -- |
Kalvista Pharmaceuticals Inc | 0.00 | -141.77m | 487.47m | 150.00 | -- | 2.81 | -- | -- | -3.54 | -3.54 | 0.00 | 4.01 | 0.00 | -- | -- | 0.00 | -78.65 | -40.63 | -87.52 | -43.67 | -- | -- | -- | -2,972.81 | -- | -- | 0.00 | -- | -- | -- | -36.31 | -- | -16.34 | -- |
SIGA Technologies Inc | 172.96m | 83.97m | 491.02m | 45.00 | 5.92 | 2.93 | 5.81 | 2.84 | 1.16 | 1.16 | 2.41 | 2.35 | 1.02 | 0.5866 | 23.09 | 3,843,484.00 | 49.52 | 22.34 | 56.21 | 27.56 | 82.00 | 88.65 | 48.55 | 41.14 | 5.65 | -- | 0.00 | 29.51 | 26.31 | -21.75 | 100.76 | -30.57 | -26.67 | -- |
Emergent Biosolutions Inc | 1.10bn | -587.00m | 496.98m | 1.60k | -- | 1.26 | -- | 0.4509 | -11.24 | -11.24 | 21.13 | 7.30 | 0.597 | 2.39 | 4.53 | 688,875.00 | -31.80 | -2.94 | -49.34 | -3.66 | 27.18 | 53.24 | -53.26 | -5.95 | 0.5438 | -1.87 | 0.6906 | -- | -6.10 | 6.05 | -259.40 | -- | -4.29 | -- |
CorMedix Inc | 806.12k | -53.12m | 512.24m | 82.00 | -- | 10.98 | -- | 635.43 | -0.9262 | -0.9262 | 0.0141 | 0.8355 | 0.014 | -- | -- | 9,830.73 | -92.57 | -54.84 | -110.35 | -62.32 | -64.79 | 6.18 | -6,589.09 | -18,323.42 | 4.43 | -- | 0.00 | -- | -100.00 | -- | -56.02 | -- | 46.27 | -- |
SNDL Inc | 669.74m | -82.92m | 519.55m | 2.52k | -- | 0.5744 | -- | 0.7757 | -0.3174 | -0.3174 | 2.56 | 3.41 | 0.5988 | 4.63 | 33.15 | 266,193.50 | -7.67 | -24.44 | -8.32 | -27.94 | 25.04 | 22.49 | -12.82 | -62.17 | 2.98 | -- | 0.1125 | -- | 27.63 | -- | 49.83 | -- | -- | -- |
Revance Therapeutics Inc | 243.90m | -283.87m | 555.28m | 597.00 | -- | -- | -- | 2.28 | -3.17 | -3.21 | 2.64 | -1.24 | 0.4466 | 1.35 | 9.18 | 408,542.70 | -51.97 | -55.55 | -61.40 | -63.20 | 71.53 | -- | -116.39 | -304.96 | 3.01 | -22.09 | 1.41 | -- | 76.55 | 128.84 | 9.10 | -- | -0.3022 | -- |
Sinovac Biotech Ltd | 429.20m | -130.73m | 639.90m | 3.04k | -- | -- | -- | 1.49 | -1.31 | -1.31 | 4.31 | 86.81 | 0.0322 | 0.2019 | 1.08 | 141,325.00 | -2.23 | 36.14 | -3.30 | 58.37 | 92.09 | 90.77 | -69.19 | 65.87 | 11.24 | -- | 0.0262 | -- | -69.97 | 14.31 | -198.16 | -- | 91.80 | -- |
Avid Bioservices Inc | 142.36m | -144.17m | 668.57m | 371.00 | -- | 11.40 | -- | 4.70 | -2.27 | -2.27 | 2.24 | 0.9192 | 0.3661 | 3.81 | 4.32 | 383,714.30 | -37.08 | -0.826 | -57.59 | -1.20 | 6.27 | 19.26 | -101.27 | -2.14 | 1.05 | -3.18 | 0.7343 | -- | -6.27 | 21.15 | -54,444.79 | -- | 84.15 | -- |
Pliant Therapeutics Inc | 0.00 | -185.41m | 676.11m | 158.00 | -- | 1.71 | -- | -- | -3.09 | -3.09 | 0.00 | 6.50 | 0.00 | -- | -- | 0.00 | -35.03 | -33.24 | -37.15 | -35.39 | -- | -- | -- | -360.29 | -- | -- | 0.0711 | -- | -83.69 | -- | -30.83 | -- | -16.89 | -- |
Holder | Shares | % Held |
---|---|---|
Tidal Investments LLCas of 31 Mar 2024 | 9.10m | 3.44% |
Cannell Capital LLCas of 31 Mar 2024 | 2.91m | 1.10% |
Global X Investments Canada, Inc.as of 30 Jun 2024 | 1.87m | 0.71% |
AdvisorShares Investments LLCas of 30 Jun 2024 | 1.41m | 0.53% |
Morgan Stanley & Co. LLCas of 31 Mar 2024 | 1.19m | 0.45% |
Millennium Management LLCas of 31 Mar 2024 | 871.51k | 0.33% |
Citadel Securities LLCas of 31 Mar 2024 | 799.36k | 0.30% |
Invesco Capital Management LLCas of 31 Mar 2024 | 784.04k | 0.30% |
Susquehanna Financial Group LLLPas of 31 Mar 2024 | 667.30k | 0.25% |
Jane Street Capital LLCas of 31 Mar 2024 | 646.26k | 0.25% |